Submitted by Anonymous (not verified) on 27 August 2026 - 9:07
Human medicines European public assessment report (EPAR): Kauliv, teriparatide, Date of authorisation: 12/01/2023, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kauliv, teriparatide, Date of authorisation: 12/01/2023, Revision: 4, Status: Authorised